Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions
Abstract
Diabetic peripheral neuropathy (DPN) is a common, incurable complication of diabetes that causes sensory loss, pain, and motor problems. Conventional treatments like blood glucose management, pain relief, and neuroprotective drugs have limited success and do not prevent disease progression. Advances in neurobiology, regenerative medicine, and bioengineering have led to novel therapies that target underlying mechanisms and promote regeneration. Monitoring and evaluating the onset and progression of DPN are essential for effective clinical management. Given rapid advances in understanding DPN and developing new treatments, a comprehensive review that covers clinical progress, molecular pathology techniques, and emerging bioengineering strategies is both timely and essential. This review addresses: (1) DPN pathophysiology; (2) drug therapies from clinical trials since 2020; (3) animal models used in DPN research; (4) progress and challenges in biomaterial-based drug delivery systems; (5) developments and limitations of microfluidic platforms for DPN modeling; and (6) bioengineered devices used for DPN diagnosis and monitoring. Integrating clinical insights, molecular techniques, and bioengineering innovations seeks to create a forward-looking framework for next-generation DPN treatment and management.
Read the paper
Related studies
- Noninvasive and Point-of-Care Surface-Enhanced Raman Scattering (SERS)-Based Breathalyzer for Mass Screening of Coronavirus Disease 2019 (COVID-19) under 5 min
- De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus)
- Molecular Characterization and Expression Profiling of Tomato GRF Transcription Factor Family Genes in Response to Abiotic Stresses and Phytohormones
- Assembly of Tight Junction Strands: Claudin-10b and Claudin-3 Form Homo Tetrameric Building Blocks that Polymerise in a Channel-Independent Manner
- Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease‐associated variants, common sequence variants, and results from newborn screening
- Machine Learning-Based SERS Chemical Space for Two-Way Prediction of Structures and Spectra of Untrained Molecules
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.